Tamoxifen and risk of large bowel cancer in women with breast cancer

Author： Newcomb P.A.   Solomon C.   White E.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.53, Iss.3, 1999-02, pp. : 271-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stroke risk and tamoxifen therapy for breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 290-291

Informa Healthcare

Access to resources Recommend Favorite

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

By Johansson Harriet   Bonanni Bernardo   Gandini Sara   Guerrieri-Gonzaga Aliana   Cazzaniga Massimiliano   Serrano Davide   Macis Debora   Puccio Antonella   Sandri Maria   Gulisano Marcella   Formelli Franca   DeCensi Andrea  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 569-578

Springer Publishing Company

Access to resources Recommend Favorite

Possible Deleterious Effect of Tamoxifen in Premenopausal Women with Locoregional Recurrence of Breast Cancer

By Borner M.M.   Bacchi M.   Castiglione M.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2173-2176

Elsevier

Access to resources Recommend Favorite

Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer

By Cheung K-L.   Robertson J.F.R.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

Evidence that Tamoxifen Preserves Bone Density in Late Postmenopausal Women with Breast Cancer

By Resch Alexandra   Biber Eva   Seifert Michael   Resch Heinrich  

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 661-664

Informa Healthcare

Access to resources Recommend Favorite